These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23265892)

  • 21. Novel gamma-secretase inhibitors uncover a common nucleotide-binding site in JAK3, SIRT2, and PS1.
    Wu F; Schweizer C; Rudinskiy N; Taylor DM; Kazantsev A; Luthi-Carter R; Fraering PC
    FASEB J; 2010 Jul; 24(7):2464-74. PubMed ID: 20237298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyridine-derived γ-secretase modulators.
    Wan Z; Hall A; Sang Y; Xiang JN; Yang E; Smith B; Harrison DC; Yang G; Yu H; Price HS; Wang J; Hawkins J; Lau LF; Johnson MR; Li T; Zhao W; Mitchell WL; Su X; Zhang X; Zhou Y; Jin Y; Tong Z; Cheng Z; Hussain I; Elliott JD; Matsuoka Y
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4832-5. PubMed ID: 21742495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of a promiscuous inhibitor shifts the inhibition from γ-secretase to FLT-3.
    Amombo GM; Kramer T; Lo Monte F; Göring S; Fach M; Smith S; Kolb S; Schubenel R; Baumann K; Schmidt B
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7634-40. PubMed ID: 23107479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monosubstituted γ-lactam and conformationally constrained 1,3-diaminopropan-2-ol transition-state isostere inhibitors of β-secretase (BACE).
    Boy KM; Guernon JM; Shi J; Toyn JH; Meredith JE; Barten DM; Burton CR; Albright CF; Marcinkeviciene J; Good AC; Tebben AJ; Muckelbauer JK; Camac DM; Lentz KA; Bronson JJ; Olson RE; Macor JE; Thompson LA
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6916-24. PubMed ID: 21782431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
    Guo T; Gu H; Hobbs DW; Rokosz LL; Stauffer TM; Jacob B; Clader JW
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3010-3. PubMed ID: 17418571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.
    Mayer SC; Kreft AF; Harrison B; Abou-Gharbia M; Antane M; Aschmies S; Atchison K; Chlenov M; Cole DC; Comery T; Diamantidis G; Ellingboe J; Fan K; Galante R; Gonzales C; Ho DM; Hoke ME; Hu Y; Huryn D; Jain U; Jin M; Kremer K; Kubrak D; Lin M; Lu P; Magolda R; Martone R; Moore W; Oganesian A; Pangalos MN; Porte A; Reinhart P; Resnick L; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Wang T; Woller K; Xu Z; Zaleska MM; Zeldis J; Zhang M; Zhou H; Jacobsen JS
    J Med Chem; 2008 Dec; 51(23):7348-51. PubMed ID: 19012391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure based design, synthesis and SAR of cyclic hydroxyethylamine (HEA) BACE-1 inhibitors.
    Rueeger H; Rondeau JM; McCarthy C; Möbitz H; Tintelnot-Blomley M; Neumann U; Desrayaud S
    Bioorg Med Chem Lett; 2011 Apr; 21(7):1942-7. PubMed ID: 21388807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of vinyl sulfones as caspase-3 inhibitors. A structure-activity study.
    Newton AS; Glória PM; Gonçalves LM; dos Santos DJ; Moreira R; Guedes RC; Santos MM
    Eur J Med Chem; 2010 Sep; 45(9):3858-63. PubMed ID: 20541849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of gamma-secretase activity by helical beta-peptide foldamers.
    Imamura Y; Watanabe N; Umezawa N; Iwatsubo T; Kato N; Tomita T; Higuchi T
    J Am Chem Soc; 2009 Jun; 131(21):7353-9. PubMed ID: 19432477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2,6-Disubstituted N-arylsulfonyl piperidines as gamma-secretase inhibitors.
    Pissarnitski DA; Asberom T; Bara TA; Buevich AV; Clader JW; Greenlee WJ; Guzik HS; Josien HB; Li W; McEwan M; McKittrick BA; Nechuta TL; Parker EM; Sinning L; Smith EM; Song L; Vaccaro HA; Voigt JH; Zhang L; Zhang Q; Zhao Z
    Bioorg Med Chem Lett; 2007 Jan; 17(1):57-62. PubMed ID: 17055268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pyridazine-derived γ-secretase modulators.
    Wan Z; Hall A; Jin Y; Xiang JN; Yang E; Eatherton A; Smith B; Yang G; Yu H; Wang J; Ye L; Lau LF; Yang T; Mitchell W; Cai W; Zhang X; Sang Y; Wang Y; Tong Z; Cheng Z; Hussain I; Elliott JD; Matsuoka Y
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4016-9. PubMed ID: 21636276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of 2,4,6-trisubstituted N-arylsulfonyl piperidines as gamma-secretase inhibitors.
    Li H; Asberom T; Bara TA; Clader JW; Greenlee WJ; Josien HB; McBriar MD; Nomeir A; Pissarnitski DA; Rajagopalan M; Xu R; Zhao Z; Song L; Zhang L
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6290-4. PubMed ID: 17890085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of benzoazepinone-derived cyclic malonamides and aminoamides as potent gamma-secretase inhibitors.
    Yang MG; Shi JL; Modi DP; Wells J; Cochran BM; Wolf MA; Thompson LA; Ramanjulu MM; Roach AH; Zaczek R; Robertson DW; Wexler RR; Olson RE
    Bioorg Med Chem Lett; 2007 Jul; 17(14):3910-5. PubMed ID: 17502143
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Click" synthesis of small-molecule inhibitors targeting caspases.
    Ng SL; Yang PY; Chen KY; Srinivasan R; Yao SQ
    Org Biomol Chem; 2008 Mar; 6(5):844-7. PubMed ID: 18292873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of cyclic sulfone hydroxyethylamines as potent and selective β-site APP-cleaving enzyme 1 (BACE1) inhibitors: structure-based design and in vivo reduction of amyloid β-peptides.
    Rueeger H; Lueoend R; Rogel O; Rondeau JM; Möbitz H; Machauer R; Jacobson L; Staufenbiel M; Desrayaud S; Neumann U
    J Med Chem; 2012 Apr; 55(7):3364-86. PubMed ID: 22380629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peptidyl allyl sulfones: a new class of inhibitors for clan CA cysteine proteases.
    Götz MG; Caffrey CR; Hansell E; McKerrow JH; Powers JC
    Bioorg Med Chem; 2004 Oct; 12(19):5203-11. PubMed ID: 15351403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. QSAR studies--potent benzodiazepine gamma-secretase inhibitors.
    Ravi Keerti A; Ashok Kumar B; Parthasarathy T; Uma V
    Bioorg Med Chem; 2005 Mar; 13(5):1873-8. PubMed ID: 15698805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ex vivo occupancy of gamma-secretase inhibitors correlates with brain beta-amyloid peptide reduction in Tg2576 mice.
    Goldstein ME; Cao Y; Fiedler T; Toyn J; Iben L; Barten DM; Pierdomenico M; Corsa J; Prasad CV; Olson RE; Li YW; Zaczek R; Albright CF
    J Pharmacol Exp Ther; 2007 Oct; 323(1):102-8. PubMed ID: 17640949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New pyrazolyl and thienyl aminohydantoins as potent BACE1 inhibitors: exploring the S2' region.
    Malamas MS; Erdei J; Gunawan I; Barnes K; Hui Y; Johnson M; Robichaud A; Zhou P; Yan Y; Solvibile W; Turner J; Fan KY; Chopra R; Bard J; Pangalos MN
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5164-70. PubMed ID: 21835615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico prediction and screening of gamma-secretase inhibitors by molecular descriptors and machine learning methods.
    Yang XG; Lv W; Chen YZ; Xue Y
    J Comput Chem; 2010 Apr; 31(6):1249-58. PubMed ID: 19847781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.